a 2016

Primary antifungal prophylaxis (PAP) with micafungin at the dose 50mg per day in adult patients with acute lymphoblastic leukaemia (ALL) during induction chemotherapy: the "real-life" evaluation.

KABUT, Tomáš, František FOLBER, Cyril ŠÁLEK, Jiřina PROCHÁZKOVÁ, Monika ROLENCOVÁ et. al.

Basic information

Original name

Primary antifungal prophylaxis (PAP) with micafungin at the dose 50mg per day in adult patients with acute lymphoblastic leukaemia (ALL) during induction chemotherapy: the "real-life" evaluation.

Authors

KABUT, Tomáš, František FOLBER, Cyril ŠÁLEK, Jiřina PROCHÁZKOVÁ, Monika ROLENCOVÁ, Michal KOUBA, Barbora WEINBERGEROVÁ, Petr CETKOVSKÝ, Jiří MAYER and Zdeněk RÁČIL

Edition

21st Congress of the European Hematology Association, 9.-12.6.2016, Copenhagen in Haematologica 2016, 101, s1, str.490, 2016

Other information

Type of outcome

Konferenční abstrakt

Confidentiality degree

není předmětem státního či obchodního tajemství
Změněno: 15/6/2016 10:18, prof. MUDr. Zdeněk Ráčil, Ph.D.